White Paper

Sustainability In Small Molecule API Manufacturing

GettyImages-2185496754-green-sustainability-graph-leaf-business-growth

Active pharmaceutical ingredient (API) manufacturing accounts for roughly a quarter of the pharmaceutical industry’s greenhouse gas emissions, making it a key area for sustainability innovation. This white paper explores how applying green chemistry principles, such as atom economy, safer solvents, and energy efficiency, can transform small molecule API production. It outlines a three-pillar approach: education and training, smart synthesis design, and measurement and optimization. Tools like DOZN™ and GreenSpeed enable data-driven decision-making and real-time sustainability assessments. Through detailed case studies, discover how process redesign, such as eliminating chromatography steps or adopting continuous flow manufacturing, can dramatically reduce waste, solvent use, and carbon footprint while improving yield and cost-efficiency. For organizations seeking actionable strategies to meet decarbonization goals, this resource offers practical, scalable solutions rooted in scientific rigor.

Explore the full white paper to see how sustainability and performance can go hand in hand.

access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma